ArticleFrontiers in pharmacology2026

Pharmacovigilance analysis of cutaneous adverse drug reactions for cetuximab, panitumumab, and necitumumab based on EudraVigilance and WHO VigiAccess.

Natalia Sauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.